Alzheimer's disease (AzD) is the most common type of dementia among older adults, with a
progressive disorder of brain that affect thinking ability, behavior, and memorizing capability …

Most Alzheimer's disease drugs do not work efficiently because of the blood–brain barrier.
Therefore, we designed a new nanopreparation (PS-DZP-CHP): cholesterol-modified …

Pharmacological treatment of central nervous system (CNS) disorders is difficult, because
the blood–brain barrier (BBB) restricts the penetration of many drugs into the brain. To solve …

Alzheimer's disease (AD) is a neurological disease that affects many of the world's rapidly
ageing population. In the etiology of Alzheimer's disease (AD), the involvement of amyloid β …

It is a very alarming situation for the globe because 55 million humans are estimated to be
affected by Alzheimer's disease (AD) worldwide, and still it is increasing at the rapid speed …

Alzheimer's disease (AD) is a multifaceted and progressive neurodegenerative disease
characterized by accumulation of amyloid-beta (Aβ) and deficits of acetylcholine …

Alzheimer's disease (AD) is the most common form of dementia and is characterized by the
cerebral accumulation of extracellular amyloid plaques. In a previous study, this …

Objectives Considerable progress has been made in the treatment of Alzheimer's disease
(AD), but all available strategies focus on alleviating symptoms rather than curing, which …

In recent years, the incidental rate of neurodegenerative disorders has increased
proportionately with the aging population. Alzheimer's disease (AD) is one of the most …

A rapid increase in incidence of neurodegenerative disorders has been observed with the
aging of the population. Alzheimer's disease (AD) is the most common neurodegenerative …